ClinicalTrials.Veeva

Menu

Giant Cell Arteritis - Optimization of Diagnostics (GAME)

Rigshospitalet logo

Rigshospitalet

Status

Completed

Conditions

Giant Cell Arteritis

Treatments

Diagnostic Test: Giant cell arteritis

Study type

Observational

Funder types

Other

Identifiers

NCT05248906
H-20032069

Details and patient eligibility

About

Giant cell arteritis - Optimization of diagnostics

Full description

A prospective study. Investigating the use of ultrasound, temporal artery biopsy, biomarkers and 18F-fluorodeoxyglucose positron emission tomography-computed tomography for establishing a diagnosis of giant cell (temporal) arteritis.

Enrollment

110 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

Clinical suspicion of giant cell arteritis

Meets the American College of Rheumatology Criteria:

Age at disease onset => 50 years New headache Temporal artery abnormality Elevated erythrocyte sedimentation rate >=50 mm/hour Abnomal artery biopsy

Exclusion criteria

Active cancer Use of steroid for more than a week (the prior 6 months)

Trial contacts and locations

1

Loading...

Central trial contact

Michael Stormly Hansen; Steffen Hamann

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems